08.27.26 -- Lower Court Agrees With WuXi AppTec (And Many Of Us)

Learn about a reputable, highly diverse screening library and fragment collection that could pave your way through a successful discovery campaign.

The heterogeneity of a biologic product has implications for the final therapy's safety and efficacy. Explore challenges associated with charged variants, including mAbs and fusion proteins.

North Carolina is a leading U.S. biopharma manufacturing hub, driven by our investment in a scalable, talent-rich, resilient, and integrated network.

Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?

Discover integrated analytical development for biosimilars, supporting characterization, comparability, validation, and regulatory submissions through co-located expertise and experience.

A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.

As demand for self-administered therapies accelerates, autoinjectors, formally known as automated needle-based injection systems (NIS-AUTO), are playing a central role in modern medicine. 

PCC boosts Protein A capture efficiency, cuts resin costs, increases productivity, and enables continuous downstream processing without sacrificing quality or compliance.

Accelerate drug development and reduce risk with parallel operations. Assimilate how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

To meet mAb, bispecific, and multispecific expression needs, sponsors require a proven cell line platform that delivers high‑titer, stable expression for complex proteins.

Adventitious agent testing is frequently a bottleneck in downstream processing. Uncover a PCR-based solution for manufacturing processes using CHO cells and animal origin-free components.